FFRCT - LAD (Distal)

The far-end reading combines pressure losses along the entire artery supplying the front of your heart. A tight narrowing, plaque spread along the vessel, and the vessel's length and shape can all lower it. A low result alone doesn't establish that one plaque restricts blood flow or needs a stent.

FFRCT stands for fractional flow reserve derived from CT. The LAD is the left anterior descending coronary artery, which supplies much of the front of your heart. Distal refers to its far end. FFRCT is an established addition to coronary CT angiography in selected people with suspected coronary disease, but the far-end value needs to be interpreted with the pressure pattern along the artery.

What the Number Represents

FFRCT estimates coronary pressure relative to pressure in the aorta. The aorta is the main artery leaving your heart. Lower values indicate a larger modeled pressure loss between the aorta and the point being evaluated.

Software builds a three-dimensional model of your coronary arteries from a CT angiogram and uses fluid-dynamics calculations to estimate pressure during maximum blood flow. This state is called hyperemia. It is simulated from a resting scan; you don't exercise during the analysis, and no pressure wire is placed inside the artery.

The result estimates the effect of the large coronary arteries on blood supply. It isn't a direct measurement of how much blood reaches your heart muscle, and a reassuring result doesn't exclude disease in the heart's smaller blood vessels.

The amount of heart muscle an artery supplies also matters. For otherwise similar narrowings, an artery supplying more muscle can have a larger pressure drop because more blood must pass through it. The LAD often supplies a large territory. In the ADVANCE registry, it had lower FFRCT values than the other major coronary arteries, although those findings weren't confined to far-end measurements.

Why the Far End Reads Lower

Pressure loss accumulates as blood travels along an artery. A long vessel that becomes smaller toward its end can therefore have a low distal value without a single severe narrowing. Plaque spread along the vessel can add to that loss.

An often-cited marathon study illustrates the problem, but its details matter. Researchers enrolled 98 symptom-free men and analyzed CT-derived flow values in the 59 who had no coronary narrowing. Nineteen of those 59 had a distal LAD result classified as abnormal by the study. The analysis used a Siemens research prototype, so this frequency shouldn't be treated as the false-positive rate of HeartFlow FFRCT.

• Vessel length and branching: a study of arteries without apparent coronary disease found that length was the strongest measured influence on LAD FFRCT, followed by the angle where the artery branched.
• A small far-end vessel: natural tapering contributes to distal pressure loss, and errors in defining a small vessel's borders can further distort the modeled result.
• Plaque spread along the artery: studies have linked plaque burden to a gradual decline in FFRCT even when there is little visible narrowing.
• A transplanted heart: distal values can be reduced without a focal flow-limiting narrowing. Findings in transplant recipients need to be interpreted within their separate evaluation for transplant-related coronary disease.

A sharp fall across one plaque and a gradual decline along a long vessel can produce similar final numbers. The pressure profile helps distinguish these patterns, but it still has to agree with the CT images. A gradual decline alone cannot reliably separate normal anatomy, diffuse plaque and modeling error.

Where the Reading Is Taken Changes the Answer

For evaluating a particular narrowing, the FFRCT value about 1 to 2 cm beyond that narrowing is generally more informative than the value at the vessel's tip. Studies comparing both locations with invasive pressure-wire FFR found fewer false-positive results at the location just beyond the plaque.

These results came from 365 vessels in 253 people. They combine the LAD and other major coronary arteries, although the advantage of the measurement just beyond the plaque was particularly clear in the LAD.

A separate study of 930 people found that 61% of positive far-end CT results were reclassified as negative when assessed just beyond the narrowing. This was a change in interpretation caused by the measurement location, not an improvement in the artery.

The size of the drop across a plaque can add information. An analysis of 4,730 ADVANCE participants estimated that incorporating this drop into a proposed referral strategy could reduce invasive angiograms by about a third. Researchers modeled that strategy using registry data; they didn't demonstrate a reduction through a randomized trial.

Heart Attack and Cardiovascular Death

Lower FFRCT values are associated with worse outcomes in people evaluated for coronary disease. The evidence usually concerns the lowest value across a person's coronary arteries or a value just beyond a narrowing. Those findings provide context for your distal LAD result, but they aren't a risk calculator for that one measurement.

A study of 7,836 people at 27 English hospitals followed outcomes for three years. Both the lowest distal-vessel value and the lowest value just beyond a narrowing were associated with subsequent events. In the analysis of values just beyond narrowings, the more severely reduced groups had about three times the adjusted risk of a heart attack compared with the reference group. The most severely reduced group also had about three times the adjusted risk of cardiovascular death. These estimates accounted for conventional risk factors and the severity of narrowing on CT.

The same study found frequent disagreement between distal and plaque-specific classifications. When the plaque-specific result was reassuring despite a reduced distal result, heart attack or cardiovascular death occurred in 1.5% over three years. That finding supports reviewing the location and pattern of pressure loss before assigning risk from the terminal value.

A pooled analysis of five studies involving 5,460 people found that death from any cause or heart attack occurred within one year in 1.4% of those classified as FFRCT-positive and 0.6% of those classified as negative. This was a little more than a twofold relative difference. It was a comparison between groups receiving clinical care, not proof that changing FFRCT itself prevents an event.

Kidney Disease and Transplant Candidates

In a study of 340 kidney transplant candidates, the group with the lowest distal FFRCT values had nearly four times the adjusted rate of major cardiac events over a median of 3.3 years compared with the study's reference group. The outcome included cardiac death, resuscitated cardiac arrest, heart attack and coronary revascularization.

The study used the lowest distal value across the coronary arteries, so the estimate isn't specific to the LAD. It found no clear association with death from any cause. Only 340 of the 553 candidates had scans that could be evaluated with FFRCT, which also limits how broadly the findings apply.

Diabetes and High Blood Pressure

In an ADVANCE analysis of 1,000 people, diabetes and hypertension were independently associated with a positive FFRCT result. The analysis concerned coronary disease across vessels, rather than the distal LAD alone.

A separate study of 1,797 people with diabetes found that CT-derived coronary physiology, HbA1c and low-density plaque each helped predict major cardiac events. That study used a different CT-FFR software platform from HeartFlow FFRCT, with its own calculation method. It supports considering physiology alongside plaque and diabetes control, but its results shouldn't be transferred directly to your distal LAD number.

When Results Can Be Misleading

• Heavy calcium: calcium can obscure the artery's borders on CT. In the FACC study of people with extensive calcification, the lowest value anywhere in the coronary arteries correctly excluded significant disease in only 32% of those without it. Measurements matched to the invasive assessment location had better specificity in a smaller subgroup. These were patient-level results, not an accuracy estimate for the distal LAD alone.
• Motion and poor contrast filling: a fast or irregular heartbeat, breathing motion or inadequate contrast can distort the reconstructed artery. Some scans cannot support a reliable analysis.
• The measurement location: the distal tip includes cumulative pressure loss along the vessel. A low tip value can overstate the contribution of a single plaque.
• Borderline estimates: agreement with pressure-wire FFR is less reliable near clinical decision boundaries. An apparently precise decimal doesn't eliminate uncertainty.
• Small-vessel disease and spasm: FFRCT models the large coronary arteries under assumed maximum-flow conditions. It doesn't directly test the function of the smallest heart vessels or diagnose intermittent coronary spasm.
• Scan preparation and previous procedures: nitroglycerin changes coronary diameter, while heart-rate control affects image quality. Stents can obscure the vessel, and bypass grafts change its circulation. Interpretation after either procedure requires particular care.

What Serial Measurements Can Show

A retrospective study of 71 people examined repeat CT scans separated by a median of 5.2 years. Changes in distal-vessel FFRCT were associated with changes in plaque and the artery's open space. The analysis included all major coronary arteries and supports studying distal FFRCT as a measure of disease over time.

It didn't establish that scheduling repeat scans to improve this number prevents heart attacks or extends life. Scan quality, software and the exact location sampled can all change the result. Even a comparison at the same location needs to account for measurement variability.